Advertisement

Molecular Analysis of Cancer Using DNA and Protein Microarrays

  • Juan Madoz-Gurpide
  • Sam M Hanash
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 532)

Abstract

In conclusion, array-based technologies have emerged that contribute to profiling tissues at the genomic, transcriptomic and proteomic levels. Analytical tools are needed to mine the vast amount of data generated. Ultimately the molecular analysis of cancer at a genome and proteome scale will allow better classification of disease and tailored individualized therapy for individual patients.

Keywords

Protein Array Protein Microarrays Protein Chip Reverse Phase Protein Array Oral Cavity Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Petricoin, E.F., Zoon, K.C., Kohn, E.C., Barrett, J.C. & Liotta, L.A. Clinical proteomics: translating benchside promise into bedside reality.Nature Reviews Drug Discovery 1683–695 (2002).PubMedCrossRefGoogle Scholar
  2. 24.
    Alizadeh, A.A.et al.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.Nature403, 503–511 (2000).PubMedCrossRefGoogle Scholar
  3. 25.
    Perou, C.M.et al.Molecular portraits of human breast tumours.Nature406, 747–752 (2000).PubMedCrossRefGoogle Scholar
  4. 26.
    Sorlie, T.et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.Proceedings of the National Academy of Sciences,USA98, 10869–10874 (2001).CrossRefGoogle Scholar
  5. 27.
    Brenton, J.D., Aparicio, S.A. & Caldas, C. Molecular profiling of breast cancer: portraits but not physiognomy.Breast Cancer Research3, 77–80 (2001).PubMedCrossRefGoogle Scholar
  6. 28.
    Gruvberger, S.et al.Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.Cancer Research61, 5979–5984 (2001).PubMedGoogle Scholar
  7. 29.
    Beer, D.G.et al.Gene-expression profiles predict survival of patients with lung adenocarcinomas.Nature Medicine8, 816–824 (2002).PubMedGoogle Scholar
  8. 30.
    Chen, G.et al.Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.Clinical Cancer Research8, 2290–2305 (2002).Google Scholar
  9. 31.
    Microarray standards at last.Nature419, 323 (2002).Google Scholar
  10. 32.
    Ge, H. UPA, a universal protein array system for quantitative detection of protein-protein, protein-DNA, protein-RNA and protein-ligand interactions.Nucleic Acids Research28, e3 (2000).Google Scholar
  11. 33.
    Rowe, C.A., Scruggs, S.B., Feldstein, M.J., Golden, J.P. & Ligler, F.S. An array immunosensor for simultaneous detection of clinical analytes.Analytical Biochemistry71, 433–439 (1999).Google Scholar
  12. 34.
    Mendoza, L.G.et al.High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA).Biotechniques27, 778–780, 782–786, 788 (1999).Google Scholar
  13. 35.
    Silzel, J.W., Cercek, B., Dodson, C., Tsay, T. & Obremski, R.J. Mass-sensing, multianalyte microarray immunoassay with imaging detection.Clinical Chemistry44, 2036–2043 (1998).PubMedGoogle Scholar
  14. 36.
    Arenkov, P.et al.Protein microchips: use for immunoassay and enzymatic reactions.Analytical Biochemistry278, 123–131 (2000).PubMedCrossRefGoogle Scholar
  15. 37.
    Haab, B.B., Dunham, M.J. & Brown, P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions.GenomeBiology2, Research0004.10004.13 (2001).Google Scholar
  16. 38.
    MacBeath, G. & Schreiber, S.L. Printing proteins as microarrays for high-throughput function determination.Science289, 1760–1763 (2000).PubMedGoogle Scholar
  17. 39.
    Schweitzer, B.et al.Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection.Proceedings of the National Academy of Sciences,USA97, 10113–10119 (2000).CrossRefGoogle Scholar
  18. 40.
    Bussow, K.et al.A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library.Nucleic Acids Research26, 5007–5008 (1998).PubMedCrossRefGoogle Scholar
  19. 41.
    Lueking, A.et al.Protein microarrays for gene expression and antibody screening.Analytical Biochemistry270, 103–111 (1999).Google Scholar
  20. 42.
    Zhu, H.et al.Analysis of yeast protein kinases using protein chips.Nature Genetics26, 283–289 (2000).PubMedCrossRefGoogle Scholar
  21. 43.
    DeWildt, R.M.T., Mundy, C.R., Gorick, B.D. & Tomlinson, I.M. Antibody arrays for high-throughtput screening of antibody-antigen interactions.Nature Biotechnology18, 989–994 (2001).CrossRefGoogle Scholar
  22. 44.
    Kononen, J.et al.Tissue microarrays for high-throughput molecular profiling of tumor specimens.Nature Medicine4, 844–847 (1998).PubMedCrossRefGoogle Scholar
  23. 45.
    Kallioniemi, O.P., Wagner, U., Kononen, J. & Sauter, G. Tissue microarray technology for high-throughput molecular profiling of cancer.Human Molecular Genetics10, 657–662 (2001).PubMedCrossRefGoogle Scholar
  24. 46.
    Paweletz, C.P.et al.Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.Oncogene20, 1981–1989 (2001).PubMedCrossRefGoogle Scholar
  25. 47.
    Pellois, J.P.et al.Individually addressable parallel peptide synthesis on microchips.Nature Biotechnology20, 922–926 (2002).PubMedCrossRefGoogle Scholar
  26. 48.
    Pawlak, M.et al.Zeptosens’ protein microarrays: a novel high performance microarray platform for low abundance protein analysis.Proteomics2, 383–393 (2002).PubMedCrossRefGoogle Scholar
  27. 49.
    Knezevic, V.et al.Proteomic profiling of the cancer microenvironment by antibody arrays.Proteomics1, 1271–1278 (2001).PubMedCrossRefGoogle Scholar
  28. 50.
    Robinson, W.H.et al.Autoantigen microarrays for multiplex characterization of autoantibody responses.Nature Medicine8, 295–301 (2002).PubMedCrossRefGoogle Scholar
  29. 51.
    Madoz-Gurpide, J., Wang, H., Misek, D.E., Brichory, F. & Hanash, S.M. Protein based microarrays: A tool for probing the proteome of cancer cells and tissues.Proteomics 11279–1287 (2001).PubMedCrossRefGoogle Scholar
  30. 52.
    Yamamoto, A.et al.Infrequent presence of anti-c-Myc antibodies and absence of c-Myce oncoprotein in sera from lung cancer patients.Oncology56, 129–133 (1999).PubMedCrossRefGoogle Scholar
  31. 53.
    Stockert, E.et al.A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.Journal of Experimental Medicine187, 1349–1354 (1998).PubMedCrossRefGoogle Scholar
  32. 54.
    Gourevitch, M.M.et al.Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.British Journal of Cancer72, 934–938 (1995).PubMedCrossRefGoogle Scholar
  33. 55.
    Gure, A.O. et al. Human lung cancer antigens recognized by autologous antibodies: Definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.Cancer Research58, 10341341 (1998).Google Scholar
  34. 56.
    Yamamoto, A., Shimizu, E., Ogura, T. & Sone, S. Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients.International Journal of Cancer22, 283–289 (1996).CrossRefGoogle Scholar
  35. 57.
    Soussi, T. The humoral response to the tumor-suppressor gene product p53 in human cancer: Implications for diagnosis and therapy.Immunology Today17, 354–356 (1996).CrossRefGoogle Scholar
  36. 58.
    Old, L.J. & Chen, Y.T. New paths in human cancer serology.Journal of Experimental Medicine187, 1163–1167 (1998).PubMedCrossRefGoogle Scholar
  37. 59.
    Le Naour, F.et al.A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis.Molecular and Cellular Proteomics1, 197–203 (2002).PubMedCrossRefGoogle Scholar
  38. 60.
    Kodadek, T. Protein microarrays: Prospects and problems.Chemical Biology8, 105–115 (2001).CrossRefGoogle Scholar
  39. 61.
    Zhu, H.et al.Protein arrays and microarrays.Current Opinion in Chemical Biology5, 40–45 (2001). Senior, K. Fingerprinting disease with protein chip arrays.Molecular Medicine Today5, 326–327 (1999).CrossRefGoogle Scholar
  40. 63.
    Eggeling, F.et al.Tissue-specific microdissection coupled with ProteinChip array technologies. Applications in cancer research.Biotechniques29, 1066–1070 (2000).Google Scholar
  41. 64.
    Madoz-GúrpideJ. et al.Modulation of electroenzymatic NADPH oxidation through oriented immobilization of ferredoxin: NADP(+) reductase onto modified gold electrodes. Journal of the American Chemical Society122, 9808–9817 (2000).Google Scholar
  42. 65.
    Delamarche, E.et al.Immobilization of antibodies on a photoactive self-assembled monolayer on gold.Langmuir, 12, 1997–2006 (1996).CrossRefGoogle Scholar
  43. 66.
    Muller, W.et al.Attempts to mimic docking processes of the immune system: recognition-induced formation of protein multilayers.Science262, 1706–1708 (1993).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Juan Madoz-Gurpide
    • 1
  • Sam M Hanash
    • 1
  1. 1.Department of Pediatrics. Comprehnsive Cancer CenterUniversity of MichiganUSA

Personalised recommendations